Nothing Special   »   [go: up one dir, main page]

CR8184A - Pirimidinas 2-sustituidas - Google Patents

Pirimidinas 2-sustituidas

Info

Publication number
CR8184A
CR8184A CR8184A CR8184A CR8184A CR 8184 A CR8184 A CR 8184A CR 8184 A CR8184 A CR 8184A CR 8184 A CR8184 A CR 8184A CR 8184 A CR8184 A CR 8184A
Authority
CR
Costa Rica
Prior art keywords
substituted pyrimidines
pyrimidines
substituted
refers
formula
Prior art date
Application number
CR8184A
Other languages
English (en)
Inventor
Tormo I Blasco Jordi
Schwogler Anja
Gewehr Markus
Muller Bernd
Grote Thomas
Grammenos Wassilios
Gypser Andreas
Rheinheimer Joachim
Blettner Carsten
Schafer Peter
Schieweck Frank
Wagner Oliver
Stierl Reinhard
Schofl Ulrich
Strathmann Siegfred
Scherer Maria
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of CR8184A publication Critical patent/CR8184A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se refiere a pirimidinas 2-sustituidas de la Formula I.
CR8184A 2003-07-24 2006-01-11 Pirimidinas 2-sustituidas CR8184A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10357714 2003-12-09

Publications (1)

Publication Number Publication Date
CR8184A true CR8184A (es) 2006-10-06

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8184A CR8184A (es) 2003-07-24 2006-01-11 Pirimidinas 2-sustituidas

Country Status (30)

Country Link
US (1) US7375108B2 (es)
EP (1) EP1651618B1 (es)
JP (1) JP2006528603A (es)
KR (1) KR20060052857A (es)
AP (1) AP2157A (es)
AR (1) AR045100A1 (es)
AT (1) ATE350370T1 (es)
AU (1) AU2004261373B8 (es)
BR (1) BRPI0412891A (es)
CA (1) CA2532718A1 (es)
CO (1) CO5660292A2 (es)
CR (1) CR8184A (es)
CY (1) CY1106391T1 (es)
DE (1) DE502004002570D1 (es)
DK (1) DK1651618T3 (es)
EA (1) EA010566B1 (es)
EC (1) ECSP066278A (es)
ES (1) ES2279395T3 (es)
HR (1) HRP20070057T3 (es)
IL (1) IL172848A0 (es)
MA (1) MA27949A1 (es)
MX (1) MXPA06000038A (es)
NZ (1) NZ545103A (es)
PE (1) PE20050882A1 (es)
PL (1) PL1651618T3 (es)
PT (1) PT1651618E (es)
SI (1) SI1651618T1 (es)
TW (1) TW200516075A (es)
UY (1) UY28436A1 (es)
WO (1) WO2005012261A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1984902A (zh) * 2004-07-14 2007-06-20 巴斯福股份公司 2-取代的嘧啶、其制备方法及其在防治致病性真菌中的用途
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
US8614223B2 (en) * 2010-11-16 2013-12-24 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
JP6626437B2 (ja) 2013-10-08 2019-12-25 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. ヒストンデアセチラーゼ阻害剤とHer2阻害剤またはPI3K阻害剤のいずれかの組み合わせ
EP3055299B1 (en) 2013-10-10 2021-01-06 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
EP3060217B1 (en) 2013-10-24 2022-06-08 Mayo Foundation for Medical Education and Research Treatment of polycystic diseases with an hdac6 inhibitor
ES2806258T3 (es) 2013-12-03 2021-02-17 Acetylon Pharmaceuticals Inc Combinaciones de inhibidores de histona desacetilasa y fármacos inmunomoduladores
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
EA201790142A1 (ru) 2014-07-07 2017-07-31 Эситайлон Фармасьютикалз, Инк. Лечение лейкоза ингибиторами гистондеацетилазы
JP2017537164A (ja) 2014-12-05 2017-12-14 ユニヴァーシティ・オブ・モデナ・アンド・レッジョ・エミリア リンパ腫の治療に使用されるヒストン脱アセチル化酵素阻害剤とベンダムスチンとの組み合わせ
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
EP3445364A4 (en) 2016-04-19 2019-11-27 Acetylon Pharmaceuticals, Inc. HDAC INHIBITORS, ONLY OR IN ASSOCIATION WITH BTK INHIBITORS, TO TREAT CHRONIC LYMPHOCYTIC LEUKEMIA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001096314A1 (en) 2000-06-13 2001-12-20 Basf Aktiengesellschaft Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
JP4361736B2 (ja) * 2001-03-15 2009-11-11 ビーエーエスエフ ソシエタス・ヨーロピア 5−フェニルピリミジン、その製造方法、製造のための中間体および有害な菌類を防除するための使用
PL371059A1 (en) 2001-11-19 2005-06-13 Basf Aktiengesellschaft 5-phenylpyrimidines, agents comprising the same, method for production and use thereof

Also Published As

Publication number Publication date
BRPI0412891A (pt) 2006-10-03
AU2004261373B8 (en) 2010-11-04
PT1651618E (pt) 2007-03-30
MXPA06000038A (es) 2006-03-21
AU2004261373A1 (en) 2005-02-10
PL1651618T3 (pl) 2007-05-31
DE502004002570D1 (de) 2007-02-15
IL172848A0 (en) 2006-06-11
JP2006528603A (ja) 2006-12-21
AP2006003497A0 (en) 2006-02-28
US20070105873A1 (en) 2007-05-10
ES2279395T3 (es) 2007-08-16
EA010566B1 (ru) 2008-10-30
KR20060052857A (ko) 2006-05-19
CY1106391T1 (el) 2011-10-12
WO2005012261A1 (de) 2005-02-10
SI1651618T1 (sl) 2007-06-30
CA2532718A1 (en) 2005-02-10
AP2157A (en) 2010-09-13
US7375108B2 (en) 2008-05-20
DK1651618T3 (da) 2007-05-14
EA200600212A1 (ru) 2006-08-25
NZ545103A (en) 2008-06-30
CO5660292A2 (es) 2006-07-31
TW200516075A (en) 2005-05-16
MA27949A1 (fr) 2006-06-01
AR045100A1 (es) 2005-10-12
HRP20070057T3 (en) 2007-07-31
EP1651618A1 (de) 2006-05-03
ECSP066278A (es) 2006-07-28
ATE350370T1 (de) 2007-01-15
PE20050882A1 (es) 2005-12-01
EP1651618B1 (de) 2007-01-03
AU2004261373B2 (en) 2010-08-19
UY28436A1 (es) 2005-02-28

Similar Documents

Publication Publication Date Title
CR8184A (es) Pirimidinas 2-sustituidas
PA8649401A1 (es) Analogos de anilino-pirimidina
CR8475A (es) Fenilalanina-amidas sustituidas por benzoilo
EA200501333A1 (ru) 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
CR9947A (es) Compuestos de pirimidinil benzotiofeno
ME01992B (me) Jedinjenje diarilhidantoina
CR8416A (es) 5,7- diaminopirazolo [4,3-d] pirimidinas con actividad inhibidora de la pde-5
CR20120421A (es) Compuestos de aminohetetoarilo o sustituidos con pirazol como inhibidores de proteina quinasa
UY29612A1 (es) Compuestos quimicos ii
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
ATE346070T1 (de) Purinderivate als kinaseinhibitoren
ATE483000T1 (de) Naphtalin-amidin-imide
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
CY1109992T1 (el) Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα
BRPI0516242A (pt) compostos tieno-pirimidina tendo atividade fungicida
PA8543701A1 (es) Fenil-heterociclil-eteres
CR8334A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables
BRPI0509731A (pt) pirazol[4,3-d]pirimidinas
CR8185A (es) Pirimidinas 2- sustituidas
BRPI0416678A (pt) pirazolpirimidinas
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
DE602004030231D1 (de) Pyrimidinonverbindungen als calcilytica
CR9578A (es) Inhibidores de la adenilato ciclasa soluble